BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 33628730)

  • 1. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy.
    Ma Y; Dong S; Li X; Kim BYS; Yang Z; Jiang W
    Front Oncol; 2020; 10():606906. PubMed ID: 33628730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives.
    Cheng Z; Shang J; Wang H; Yu L; Yuan Z; Zhang Y; Du Y; Tian J
    J Control Release; 2023 Oct; 362():97-120. PubMed ID: 37625599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
    Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
    Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy.
    Tang Y; Liu X; Sun M; Xiong S; Xiao N; Li J; He X; Xie J
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments.
    Bahmani L; Ullah M
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Promise to Reality: Bioengineering Strategies to Enhance the Therapeutic Potential of Extracellular Vesicles.
    de Almeida Fuzeta M; Gonçalves PP; Fernandes-Platzgummer A; Cabral JMS; Bernardes N; da Silva CL
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy.
    Jiang L; Vader P; Schiffelers RM
    Gene Ther; 2017 Mar; 24(3):157-166. PubMed ID: 28140387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles.
    Jurgielewicz B; Stice S; Yao Y
    Aging Dis; 2021 Sep; 12(6):1476-1493. PubMed ID: 34527423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.
    Ullah M; Qiao Y; Concepcion W; Thakor AS
    Stem Cell Res Ther; 2019 Nov; 10(1):347. PubMed ID: 31771657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective applications of extracellular vesicle-based therapies in regenerative medicine: implications for the use of dental stem cell-derived extracellular vesicles.
    Wang W; Xu Z; Liu M; Cai M; Liu X
    Front Bioeng Biotechnol; 2023; 11():1278124. PubMed ID: 37936823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.